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1. Introduction 
The direct biochemical identification of fl-adrener- 
gic receptors in fat cell membranes was first reported 
by Williams et al. [ 11, who showed the existence of 
specific binding sites for the labeled P-antagonist (-)- 
[3H]dihydroalprenolo1 ( [3H]DHAP) having the char- 
acteristics expected of Padrenergic receptors. In these 
studies, transformation of the steady-state 13H]DHAP 
binding data to a Hill plot [2] yielded an apparent Hill 
coefficient significantly less than unity (0.65) suggest- 
ing the existence of either heterogeneous @ntagonist 
binding sites with different affinities or negatively 
cooperative interactions between these binding sites 
[2]. Confirmation of these peculiar steady-state bind- 
ing data was later provided by two recent reports, one 
concerning the influence of altered thyroid states on 
fat cell adenylate cyclase-coupled &adrenergic-recep- 
tors [3 ] and the other concerning the influence of 
age and cell size on adipocyte fl-adrenergic receptors 
[4]. Both of these studies howed, indeed, that 
Scatchard [S] analysis of the steady-state binding 
of [‘HIDHAP to rat adipocyte membranes yields 
curvilinear plots with upward concavity. 
Since steady-state binding data alone cannot dis- 
Abbreviations: [ )H]DHAP, (-)-[ 3H]dihydroalprenolol; 
Gpp(NH)p, guanosine 5’-(&y-imino)triphosphate 
This work was presented as a short communication at the 
fist international Colloquium on Receptors, NeurotrFs- 
mitters and Peptide Hormones (13-l 8 May 1979, Capri) 
tinguish between the negative cooperativity model 
and the existence of heterogeneous populations of 
binding sites, the present investigations were under- 
taken to determine whether the /3-adrenergic recep 
tors of white fat cells display cooperative site-site 
interactions or not. During the course of these 
investigations, a report [6] provided some evidence 
against the existence of negatively cooperative inter- 
actions among the /_%adrenergic antagonist-binding 
sites of rat fat cell membranes. In the present studies, 
we not only confirm this interpretation but also pro- 
vide some evidence in favour of the heterogeneity of
adipocyte Padrenergic agonist binding sites. 
2. Materials and methods 
2.1. Pvepamtion of crude adipoqyte membranes 
Male Wistar ats (CERJ, 225-250 g) were fed ad 
libitum before being sacrificed by decapitation. Epi- 
didymal fat pads from IO-15 rats were pooled and 
isolated fat cells prepared as in [7]. Crude adipocyte 
membranes prepared as in [4], were fmally suspended 
in 10 mM MgCls, 50 mM Tris-HCl (medium I) result- 
ing in a suspension containing 3-4 mg protein/ml 
which was used in the binding assays. Protein was 
determined according to Lowry [B] using bovine 
serum albumin as a standard. 
2.2. Binding assays 
Binding assays were performed using daily-prepared 
crude membranes as in [4,9]. In brief, membrane 
(1 SO-175 pg) was incubated usually with 20 nM 
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[3H]DHAP in medium I for 8 min with shaking at 
37°C. Incubations were terminated by adding ice-cold 
buffer followed by rapid vacuum filtration through a 
Whatman GFC glass fiber filter. Filters were rapidly 
washed, dried, added to scintillation cocktail (MI 96, 
Packard) and counted. Non-specific binding, deter- 
mined by measuring the radioactivity remaining on 
filters when incubations were performed with a large 
excess (20 PM) of (+)-alprenolol, averaged 20-25% 
of the counts specifically bound to adipocyte mem- 
branes. 
2.3. Dissociation kinetics studies 
Negative cooperativity among P-receptors was 
assessed by applying the direct kinetic method [lo]. 
Membranes were incubated with 15 nM [3H]DHAP 
in medium I at 25°C for 30 min (time corresponding 
to binding equilibrium at this temperature), after 
which 100 ~1 aliquots were transferred in 9.9 ml 
medium I containing or not 10 I.~M unlabeled (-)-pro- 
pranolol, (-)-alprenolol or (-)-isoproterenol and fur- 
ther incubated at 25 or 37°C. At appropriate inter- 
vals, duplicates from each set (with or without 
unlabeled compounds) were filtered, washed, dried 
and counted as described above. Radioactivity speci- 
fically bound to the membranes was expressed as per- 
centage of the radioactivity specifically bound at time 
zero (time immediately after the 1: 100 dilutions). 
2.4. Other determinations 
In competition experiments, equilibrium dissocia- 
tion constant, K, for the interaction of the binding 
sites with each of the unlabeled compounds tested 
for their ability to compete with [3H]DHAP was 
calculated as in [ 111. In these experiments, analysis 
of the resulting data by Hill plots was performed 
taking as Bmax, the specific radioligand binding 
occurring in the absence of any displacing agent, and 
as B the percentage of B,, displaced at any concen- 
tration of displacing agents; data were then plotted as 
log (% B,,/lOO%-% 8,,) versus log (displacer) to 
yield the Hill plot [ 121. 
2.5. Chemicals 
(-)-[3H]Dihydroalprenolo1 (spec. act. 39 Ci/mmol) 
was prepared by the Radiochemical Centre (Amersham) 
with a radiochemical purity (monitored by thin- 
layer chromatography) X8%. (+)-Alprenolol 
432 
was a gift from Laboratories Lematte t Boinot. Other 
compounds used in this study were: (-)-isoproterenol 
bitartrate (SigmaChemical Co., USA), (-)-propranolol 
which was kindly supplied by ICI Pharma (France) 
and 5’-guanylyl-imidodiphosphate (Gpp(NH)p) from 
Boehringer (FRG). 
3. Results 
Hill transformation of the steady-state specific 
binding of the b-antagonist [3H]DHAP to adipocyte 
membranes yielded an apparent Hill coefficient of 
0.73 with a dissociation constant K, of 22 nM (data 
not shown), confirming thus published results [1,3,4]. 
The specific binding of /I-adrenergic agonists to 
adipocyte membranes was studied by measuring the 
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Fig.1. (-)-Isoproterenol binding to the p-adrenergic receptors 
of rat fat cell membranes. Effect of Gpp(NH)p. Specific 
binding of (-)isoproterenol in the absence or presence of 
100 PM Gpp(NH)p was assayed by competition for [ ?-I]di- 
hydroalprenolol binding sites as follows: membranes were 
incubated with 20 nM [3H]dihydroalprenolol and with 
increasing concentrations of (-)-isoproterenol in the absence 
or presence of 100 PM Gpp(NH)p. The amount of dihydroal- 
prenolol specifically bound was then determined and the 
results expressed as percent of the amount bound in the 
absence of (-)-isoproterenol. Data concerning (-)isopro- 
terenol alone are means of 4 separate xperiments performed 
in triplicate. Data concerning Gpp(NH)p + (-)-isoproterenol 
are means of two experiments performed in triplicate. Disso- 
ciation constants calculated according to [ 111, were: Kd for 
isoproterenol = 150 nM ;Kd for isoproterenol with Gpp(NH)p 
= 500 nM. 
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Fig.2. Apparent Hill coefficient of (-)-isoproterenol binding 
to adipocyte p-adrenergic receptors. Effect of Gpp(NHIp. 
Data in fig.1 were transformed into Hill plots as in section 2. 
Apparent Hill coefficient nN and dissociation constants Kd 
values given in the figure were calculated by regression analysis. 
displacement of [3H]DHAP specifically bound by 
increased (-)isoproterenol concentrations. As shown 
in fig. 1, the resulting competition curve was rather 
broad yielded an app. Kd for (-)-isoproterenol of 
0.15 rl 0.09 PM (mean f SEM of 4 separate experi- 
ments). These competition data have been trans- 
formed as Hill plots as in section 2 (fig.2) and as 
Scatchard plots (fig.3) following a modified Scatchard 
analysis [5] in which the amount of specific [3H]- 
DHAP binding displaced at each (-)-isoproterenol 
concentration has been assumed to represent the 
amount of agonist specifically bound at the corre- 
sponding agonist concentration. 
This type of analysis was acceptable under the 
experimental conditions used since the fraction of 
total [3H]DHAP bound to the membranes in the 
absence of competition ligand was <lO% of the free 
radioactive or competitive ligand, indicating that the 
concentration of these ligands is relatively constant 
and that variations in these fractions would be 
unlikely to influence graphical analysis. As shown in 
fig.2, the Hill plot drawn from the data in fig.1, 
yielded an apparent Hill number of 0.52 4 0.08 
(mean f SEM of 4 separate experiments), a value 
which is consistant with either negatively cooperative 
interactions between agonist receptor sites or with 
the existence of two or more independent binding 
sites. Scatchard analysis of the data in fig.1 yielded, 
as in the case of&adrenergic antagonist binding [2-4], 
a peculiar curvilinear plot with upward concavity (fig.4): 
Separate regression analysis of the data obtained with 
isoproterenol concentrations at <SO0 nM and of the 
data obtained with higher concentrations provided a 
strong evidence in favour of the existence of two 
apparent orders of binding sites, one with high affin- 
ity for (-)-isoproterenol (Kd = 33 nM, r = 0.95) and 
one with low affinity (& = 700 nM, r = 0.95). 
As shown in fig. 1, the slope of the competition 
curve for (-)-isoproterenol approached that described 
by a Hill coefficient of 1, when competition was per- 
formed in the presence of 100pM Gpp(NH)p, a nucleo- 
tide which reduces the P-receptor affinity for agonists 
in adipocytes [13] as it does in other cells [14,15]. 
This was confirmed by the data in fig.2 showing that 
Gpp(NH)p induces indeed a shift of the apparent Hill 
Fig.3. Scatchard analysis of (-)-isoproterenol binding to the 
padrenergic receptors of rat fat cell membranes. Effect of 
Gpp(NH)p. Binding data of fig.1 were analysed according to 
Scatchard [S 1. The apparent two orders of binding sites and 
their respective dissociation constants were calculated by 
regression analysis. The point of inflection between the lines 
was arbitrarily decided when the high affinity component 
giving the highest correlation coefficient was calculated. 
Kd for the high affinity sites (isoproterenol concentra- 
tions between 10 and 500 nM) was 33 nM with a correlation 
coefficient r = 0.95; for the low affinity sites (isoproterenol 
concentrations above 500 nM), the cakdated Kd value was 
700 nM with r = 0.95. 
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Fig.4. Ability of p-adrenergic agonists and antagonists to 
increase the rate of dissociation of specific [ 3H]dihydroal- 
prenolol binding. Membranes were preincubated with 15 nM 
[ 3H]dihydroalprenolol at 25°C for 30 min, then diluted 
1: loo-fold into buffer containing or not the unlabeled 
p-adrenergic agonist or antagonist and further incubated at 
25’C. Samples were filtered at the indicated times and 
counted for specific binding. Each point is the mean of 
2 separate xperiments performed in duplicate (vertical ines 
= 1 SEMI. 
number of (-)isoproterenol binding to a higher value 
(nH = 0.84, r = 0.98) which could be more consistant 
with the existence of a single set of agonist binding 
sites, under these conditions. On the other hand, 
Scatchard analysis of (-)-isoproterenol binding in the 
presence of Gpp(NH)p, indicates that this nucleotide 
selectively reduces the affinity of the apparent high 
affinity order of binding sites (fig.3). 
Existence of negatively cooperative site-site inter- 
action was tested by studying the influence of /3-adre- 
nergic ligands on the kinetics of the [3H]DHAP-recep- 
tor complex dissociation that follows a 1 : 100 dilu- 
tion of membranes containing an excess of free recep- 
tors. These conditions were found to be adequate to 
prevent [3H]DHAP rebinding during the dissociation 
phase. 
As shown in fig.4, addition of an excess (10 PM) 
of (->isoproterenol or (-)propranolol resulted in an 
only slight (4-9%) and non-significant increase in the 
[3H]DHAP dissociation rate at 25°C as compared 
with dissociation by dilution alone. 
4. Discussion 
Several reports have shown that the steady-state 
binding of radioligands to some hormone-receptors 
yields Hill numbers of <l .O and/or curvilinear 
Scatchard plots with upward concavity. For some of 
these hormones [ 10,16-211, existence of negative 
cooperativity among their specific receptors has been 
postulated to be the basis of this non-classical way of 
binding. Indeed, the dissociation of the labeled hor- 
mones from their specific receptors was demonstrated 
to be significantly accelerated by unlabeled hormones 
in the case of polypeptide hormones such as insulin 
[10,16] and nerve growth factor [17,18] and glyco- 
peptide hormone such as thyroid stimulating hormone 
[ 191. Thus, negative cooperativity among hormones 
and their receptors appears to be a rather widespread 
phenomenon. 
In the case of catecholamines, however, negative 
cooperativity among fl-adrenergic receptors seems so 
far to be specific to the frog erythrocyte [2] and 
Hela cell [21] membranes. In fact, numerous recent 
studies on the @-adrenergic receptors of turkey erythro- 
cytes [22], rat liver [23], brain [24,2.5], glioma cells 
[26], parotid [27], erythrocytes [28], skeletal muscle 
[29] and heart [30], strongly suggest he existence 
of one type of binding site displaying no apparent 
negatively cooperative site-site interactions. Moreover, 
evidence against negative cooperativity among the 
P-adrenergic receptors of another catecholamine tar- 
get cell, the adipocyte was recently provided by 
Malbon and Cabelli [6] who reported an insignificant 
acceleration of [3H]DHAP dissociation by antagonists 
and agonists, a result which is confirmed here. 
Analysis of the steady-state binding of [3H]DHAP 
and of (-)-isoproterenol (drawn from competition 
curves) to rat fat liver membranes yields Hill plots 
with Hill numbers of <l .O (0.73 for [3H]DHAP and 
0.52 for (-)-isoproterenol). Thus, because of the 
absence of discernable negative cooperativity, the 
most likely explanation for these low nH values is 
that /3-adrenergic antagonist- and agonist-binding sites 
exist in the fat cell as multiple populations with dif- 
ferent affinities. 
In the case of (->isoproterenol-receptor sites, the 
data reported in fig.3 are in favour of the existence, 
in approximately equivalent proportions, of two 
apparent orders of binding sites with. respectively, 
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high and tow affmity for (-)-is.oproterenoI. This 
apparent dual binding, a phenomenon which has 
been already found in our laboratory for the specific 
but non-receptor (-)j3H]norepinephrine binding 
sites of intact rat epididymal fat cells [3 I], could 
reflect the heterogeneous nature of the biological 
preparation used (crude membranes). This hypothesis 
appears, however, unlikely if one considers the data 
f 11 showing that the specificity and affinity charac- 
teristics of the [~]~H~-receptor sites of a highly 
enriched plasma memb~e fraction of rat adip~ytes 
are virtually identical with those of the eorre~ondjng 
u~ractionated membranes. 
The existence of such two orders of binding sites 
for (-)-isoproterenol in adipocyte membranes i  to be 
compared with the results of [32]. These authors, 
using also the Scatchard analysis of [3H]DHAP binding 
inhibition by selective fll and pz competitive ligands 
(agonists and antagonists, showed indeed the existence 
of two distinct orders of binding sites for each &- and 
~~~adre~ergic receptor subtypes of rat and rabbit lung 
membranes [32]. In the case of rat fat cells, &adre- 
nergic responses are p~do~~tly if not exclusively 
of the &-subtype [33]. It is thus tempting to consider 
that the 2 apparent (-)-isoproterenol binding sites 
presently found represent 2 distinct isoproterenol 
binding sites among which only the high affmity one, 
because of its low app. K, which is more compatible 
with the nM range of blood catecholamine l vels [34] 
than the K, of the Iow afcmity binding site, may well 
represent the true active &-adrenergic receptors of 
rat fat cells. As an additional support o this hypoth- 
esis is the fact that the affinity of these binding sites 
appears to be seIective& altered by Gpp(NH)p, an 
analog of GTP which is involved in the coupling of 
adenylate cyclase to the fi-adrenergic receptors [35]. 
Finally, if these apparently high affinity binding sites 
represent the true /3-adrenergic re eptors of rat fat cells, 
this would indicate that methods based an the mea- 
surements of [3H]DHAP binding may overestimate 
and consequently be inadequate to assess the number 
of&adrenergic receptors in these preparations. Experi- 
ments using the radiolabeled &agonist (--)-@I- 
hydroxybe~y~sop~terenoI [36] are currently in 
progress to test the validity of these hypotheses. 
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